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Abstract 
Recruiting high-risk, HIV-negative participants is challenging for HIV prevention trials. This study aimed to 1) 
identify and characterize subsets of high-risk women based on responses to demographic and psychosocial 
questions from the AIDS Indicator Survey (AIS) and 2) develop a rapid, inexpensive tool for site identification. 
We developed a latent class model (LCM), hypothesizing that AIS respondents could be grouped by responses 
to psychosocial indicators, and that these latent classes would vary by HIV status, socio-demographic, and 
other indicators. We tested our model on women respondents from the Tanzania 2003 AIS Survey, and 
replicated it in several other populations.  LCM produced four classes of women who significantly varied by 
psychosocial indicators and HIV status. Geographic differences in HIV prevalence and class composition were 
observed. Our approach has the potential to provide a more systematic, inexpensive and rapid strategy to 
identify HIV prevention trial sites. 
 




Le recrutement de participants à haut risque de VIH, mais VIH-négatifs, est un défi pour les essais cliniques. 
Cette étude visait à 1) identifier et caractériser des sous-groupes de femmes á haut risque d’acquisition à 
partir  de leurs réponses aux questions démographiques et psychosociales de l’Enquête sur les Indicateurs du 
SIDA (EIS) et 2) de développer un outil rapide et économique pour appuyer l’identification de lieux de 
recrutement. Nous avons développé un modèle à classes latentes  (MCL) sous l’hypothèse que les 
participantes puissent être regroupées en fonction de leurs réponses aux questions psychosociales, et que les 
classes latentes varient en terme de statut VIH, d’indicateurs sociodémographiques, et d’autres indicateurs.  
Nous avons testé notre modèle en utilisant les données de l’enquête EIS conduite en Tanzanie en 2003, et 
l’avons ensuite répliqué sur d’autres populations. Le modèle MCL a produit 4 classes de femmes  différant de 
manière significative en termes des indicateurs psychosociaux et du statut VIH.  Des différences ont été 
constatées au niveau de la prévalence du VIH et de la composition des classes entre les différentes zones 
géographiques.  Notre approche pourrait offrir une stratégie systématique, économique, et rapide pour 
l’identification de sites de recrutement pour les essais cliniques. 
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Introduction 
Efforts to develop new HIV prevention 
technologies, including vaginal microbicide gels and 
films, oral pre-exposure prophylaxis (PrEP), and, 
more recently, longer-acting vaginal rings and 
injectables, have spanned almost three decades and 
included approximately 50 different pharmaceutical 
products formulated and/or delivered through a 
range of approaches (Stone and Harrison 2010). 
While more than a dozen products have moved 
from preclinical/ laboratory evaluation into human 
clinical trials to evaluate longer-term safety, 
acceptability and effectiveness, only three HIV 
prevention approaches, thus far, have demonstrated 
evidence of effectiveness. Three clinical trials of 
either tenofovir alone, or Truvada (tenofovir in 
combination with emtricitibine), concluded that the 
pre-exposure prophylactic (PrEP) use of ARVs taken 
orally could reduce HIV transmission in heterosexual 
discordant couples and among men-who-have-sex-
with men (Grant, Lama et al. 2010, Baeten, Donnell 
et al. 2012).   In addition, the CAPRISA 004 clinical 
trial in South Africa produced a proof of concept for 
the vaginal use of tenofovir 1% gel when used peri-
coitally in reducing HIV transmission to heterosexual 
women (Abdool Karim, Abdool Karim et al. 2010). 
Despite these recent successes, HIV prevention 
development efforts have faced a number of 
challenges along the way. One major challenge has 
been the ability of clinical trials implementers to 
recruit sufficiently high-risk but HIV-negative women 
(Skoler 2006). The difficulty is four-fold. First, 
methods for identifying geographic localities with 
high HIV incidence are problematic. Clinical trials 
may rely on pre-trial roll-in studies to calculate 
incidence (Ramjee, Kapiga et al. 2008, Feldblum, 
Latka et al. 2012) – an approach that is both costly 
and time-consuming. Newer and more sensitive 
blood tests or testing algorithms are promising 
(Hecht, Wellman et al. 2011, Combes, A et al. 
2013), but may be expensive and pose logistical 
problems if individual diagnosis requires that more 
than one test is given, or ethical hurdles if the 
expectation of inflated estimates precludes 
individual-level diagnosis. Second, researchers’ 
efforts to target “high-risk” populations may miss 
the mark. For example, while several first 
generation microbicide trials focused recruitment on 
women engaged in commercial sex work, incidence 
rates realized within the trials did not provide for a 
sensitive test of product effectiveness (Feldblum, 
Adeiga et al. 2008, Halpern, Obunge et al. 2009). 
Some research had suggested that HIV risk may be 
less determined by the number of sex partners or 
frequency of sex, than by characteristics of the 
sexual relationship (Nagot, Ouedraogo et al. 2005, 
Karim, Kharsany et al. 2011, Ramjee 2011, Dunkle 
and Decker 2013). Indeed, women who 
acknowledge sex work may have greater ability to 
negotiate condom use, at least with clients and 
casual partners, than other women. Third, by 
focusing recruitment efforts on women who feel 
capable of adhering to the trial protocol – in other 
words, women who perceive greater self-efficacy - 
microbicide trials may recruit women who are at 
lower risk of HIV. Finally, trial implementers have 
increasingly conducted their studies in a small 
number of geographic areas, especially in regions of 
South Africa with continued high incidence rates – 
potentially leading to the emergence of a class of 
professional trial participants who may enrol in one 
or even multiple clinical trials without a real 
commitment to adhere to product use (Karim, 
Kharsany et al. 2011). 
Literature Review and Theoretical 
Framework 
In the past decade, Measure/Demographic and 
Health Survey (DHS) has introduced an HIV 
biomarker component into over 30 countries, 
including Tanzania and Côte d’Ivoire (Measure DHS 
2013). We set out to determine whether use of 
DHS data could assist in identifying and 
characterizing sub-populations within a given 
country who might be at greater risk of HIV 
infection for the purpose of identifying sites for 
future prevention trials. Our approach is based on 
“market segmentation” analyses that were originally 
developed by marketing and business firms, but have 
been adopted by health communications specialists. 
In short, this approach uses individual data on 
psychosocial indicators to develop class profiles 
towards which to tailor their marketing or 
communication activities (Barry and Weinstein 
2009).  
The goals of this analysis were to 1) identify and 
characterize subsets of women at a country, region 
or sub-regional level who are at high risk of HIV, 
based on their responses to demographic and 
psychosocial questions currently collected by DHS; 
and 2) develop a rapid and inexpensive tool for 
identifying population segments in specified 
countries at high risk of HIV.   
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Conceptual Model 
Behavioural theories identify how psychosocial 
factors predict health behaviours which in turn 
influence health status (Glanz, Rimer et al. 2008).  
Several theories have been applied to examining HIV 
risk and adoption of prevention behaviours, 
including the AIDS Risk Reduction Model (ARRM) 
(Catania, Kegeles et al. 1990), the Information, 
Motivation and Behaviour Change theory (Fisher and 
Fisher 1992) and the Risk Perception Attitudes 
Framework (Rimal, Brown et al. 2009). They share 
similar constructs. The ARRM posits that, prior to 
sustaining a complex behaviour like consistent 
condom use, individuals must first perceive or 
“label” themselves to be at risk, commit to changing 
their risky behaviour and then enact the new 
behaviour. Commitment requires both knowledge 
of prevention options and belief that the individual 
has the ability to engage in these new behaviours. An 
individual’s perceived ability, or self-efficacy, to 
adopt new prevention behaviours is essential to 
enacting, and eventually sustaining them. The IMB 
suggests that an individual must have appropriate 
information about HIV transmission and prevention 
behaviours, strong motivation and a range of 
behavioural skills to successfully carry out HIV 
prevention behaviours like condom use. Both 
perceived vulnerability to HIV and normative 
attitudes towards HIV and prevention behaviours 
influence an individual’s motivation for behaviour 
change. According to the IMB, AIDS-related 
information and motivation work directly through a 
number of behavioural skills (for example, acquiring 
new information, communicating with a partner or 
purchasing condoms), which in turn enable an 
individual to reduce his/her risk for HIV.  As in the 
ARRM, self-efficacy is a critical component of 
behavioural skills. Finally, the Risk Perception 
Attitudes Framework focuses on two of the above 
constructs, suggesting that the strength of an 
individual’s efficacy beliefs will influence whether or 
how his or her risk perceptions affect the uptake of 
prevention behaviours (Rimal, Brown et al. 2009). 
For example, when a person’s efficacy beliefs and 
risk perception are low, s/he will not be adequately 
motivated to engage in new prevention behaviours, 
while low risk perception but strong efficacy beliefs 
will cause a person to engage in proactive 
behaviours. In contrast, a person with high risk 
perception but low efficacy beliefs is likely to engage 
in “avoidance” behaviours.   
The Risk Perception Attitudes Framework has 
been used to identify different population segments, 
based on their HIV-related perceived risk and 
efficacy beliefs, in order to develop and disseminate 
communication materials tailored to the needs of 
each audience segment (Rimal, Brown et al. 2009).  
We adapt and extend this approach, but using 
psychosocial constructs to identify population 
segments with potentially different predispositions 
to HIV prevention. Our assumption is that the 
different psychosocial profiles of our population 
segments will be related to underlying risk profiles 
that predict HIV status – and can be used to better 
tailor recruitment strategies for HIV prevention 
trials. 
The diagram below presents our conceptual 
model for this study.  It suggests that population 
sub-groups (or, latent classes) will be characterized 
by different levels of HIV knowledge, perceived and 
demonstrated efficacy for HIV or related health 
behaviours, attitudes towards HIV norms and HIV 
risk perception, and that these classes will differ with 
respect to actual HIV risk.  Further, socio-
demographic, geographic, and household 
characteristics, as well as HIV risk indicators, will 
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Diagram 1: Latent Class Model for Population Segmentation 
 
Data and Methods 
Our original model was developed and tested on 
data from female respondents to the Tanzania 2003-
04 HIV/AIDS Indicator Survey (AIS) DHS IV Release 
Version 0, and further replicated using Tanzania 
2003-04 male data and on a second female dataset 
from the Côte d’Ivoire 2005 AIS DHS V Release 
Version 0. (Data for Tanzania males and Cote 
d’Ivoire females are not presented in this paper.) We 
attempted to further replicate the model on more 
recent data from the 2011-12 AIS DHS VI Release 
Version 1 in Tanzanian females. Below, we describe 
the samples and measures for the Tanzania AIS 
2003-04 and 2011-12 models in women.  
Tanzania AIS 2003-2004 Sample: The total 
sample of women in the Tanzanian DHS/AIS was 
6863. A total of 1733 women were excluded for at 
least one of three reasons: their HIV test result was 
missing; they reported either never having had sex; 
or, they reported having been previously tested for 
HIV, were diagnosed as HIV-positive and knew their 
results. This last category of women was excluded 
from our sample in order to reduce the likely effect 
that such knowledge would have on subsequent 
reporting of HIV-related knowledge, attitudes and 
behaviours; in a sense, we were hoping to better 
approximate HIV incidence, as opposed to 
prevalence, using this restriction.  Finally, 562 
women who were missing data for at least one 
predictor variable were excluded from the model. 
Our final sample included 4,568 sexually active 
women for whom an HIV test result existed and 
who were either negative or did not know the result 
of their positive, anonymous test. 
Tanzania 2011-2012 AIS Sample: We used the 
same algorithm to determine our 2011-12 sample. 
In this sample, a total of 10,299 women had both 
DHS survey data and AIS biomarker data. However, 
2037 women were excluded because they reported 
either never having had sex, had a missing HIV 
result, or they reported having been previously 
tested for HIV, were diagnosed as HIV-positive and 
knew their test result. An additional 941 women 
were excluded from the model because they were 
missing data on at least one predictor variable.  Our 
final model included data for 7,321 sexually active 
women for whom an HIV test result existed and 
who were either HIV-negative or did not know the 
result of their positive, anonymous test. 
Measures: 
Table 1 summarizes the variables used in our 
models, by year. The main study outcome was HIV 
status, either positive or negative. (HIV status was 
determined by a central laboratory, based on a 
standard algorithm using two different HIV antibody 
ELISA tests of dried blood spots collected through 
finger prick (Mishra, Medley et al. 2009).) 
Four sets of psychosocial variables were used as 
indicators for the latent classes: HIV Knowledge, 
HIV Norms, Self-Efficacy, and Risk Perception. An 
HIV Knowledge score was computed by summing 
correct responses to 15 items in the 2003-04 AIS, 
but only 10 items in the 2011-12 AIS, assessing 
knowledge about potential modes of HIV 
transmission. Some examples of items include: Can 
people get the AIDS virus from mosquito bites? and 
Can people reduce their chances of getting the AIDS 
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Each correct response received one point; incorrect 
responses, including a response of “don’t know”, 
received 0 points.    
We used exploratory factor analysis to derive a 
summary HIV Norms score for each respondent, 
using questions measuring tolerance towards HIV – 
infected individuals (9 items in 2003 and 6 in 2012).  
We extracted a single factor using principal factor 
methods (Hatcher 1994). Examples of HIV Norms 
items include: Would you shake hands with 
someone who is infected with the virus that causes 
AIDS? and If a male teacher has the AIDS virus but is 
not sick, should he be allowed to continue teaching 
in the school?  Scores were standardized to range 
between 0 and 1 with 0 indicating no agreement 
with any of the items and 1 indicating agreement 
with all of the items. 
Self-Efficacy was measured by three items, 
including the questions: Can you say no if you don’t 
want to have sex?, Can you ask your partner to use 
a condom? (2011-12 only), and Do you know a place 
where you could get a HIV test if you wanted to? 
We also derived a score to assess the level of 
efficacy a respondent reported in relation to 
obtaining an HIV test.  In 2003-04, this score was  
derived from two questions:: I don’t want to know 
the results, but have you ever been tested to see if 
you have the AIDS virus?, and The last time you had 
the test, did you yourself ask for the test, was it 
offer to you and you accepted, or was it required? 
Those who had never been tested received a score 
of 0; if testing was required, they received a score of 
1; being offered and accepting a test was scored 2; 
and requesting a test was scored 3.  In 2011-12, the 
second question was replaced with On your most 
recent HIV test, did you get the results of your test?  
Those who had never been tested again scored 0, 
those who had been tested but did not receive the 
results of their most recent test scored 1, while 
those who did receive their most recent results 
scored 2. 
HIV Risk Perception was measured by the 
question, scored 0-3, Do you think your chances of 
getting AIDS are small, moderate, great or no risk at 
all? This question was not included in the Tanzania 
2011-12 AIS. Finally, standard socio-demographic, 
household, geographic and HIV risk indicators were 
drawn from the AIS dataset and are shown in Table 
1. 
Data Analysis 
We used latent class analysis (LCA) with a distal 
outcome (HIV) to fit the model depicted in Figure 1, 
using Mplus, version 7 (Muthén and Muthén 2012).  
This is an exploratory modelling approach that 
assumes the population is comprised of an unknown 
number of distinct HIV risk classes.  We first 
determined the number of latent classes using 
simplified models that included only the four sets of 
psychosocial variables and HIV status.  We fit models 
with two to five classes and used the Bayesian 
information criterion, Lo-Mendell-Rubin likelihood 
ratio tests, and a subjective assessment of overall 
interpretability to select the final number of classes. 
Finally, we added the predictor variables to the 
model with the selected number of classes.  Latent 
class analysis does not explicitly assign women to 
classes but rather predicts posterior class 
membership probabilities for each woman. To 
facilitate comparisons across classes, we assigned 
women to classes based on their highest posterior 
probabilities.  We used analysis of variance or chi-
squared tests, respectively, to compare continuous 
or categorical characteristics across classes.  All 
analyses other than the LCA were conducted using 
SAS, version 9.2 (SAS Institute, Cary, NC). 
Results 
In the original analysis of AIS 2003-04 data, four 
classes emerged from the latent class modelling 
based on women’s responses to HIV knowledge, 
norms, self-efficacy and risk perception constructs 
(Table 2). All six variables showed significant 
differences between classes (p<0.001 for each). 
Class membership also varied by the socio-
demographic, household, geographic and risk 
variables that were included in the model as 
predictors.  
Examination of the latent class and predictor 
variables helped us develop labels for the four 
classes. For example, the first and largest, or 
“Typical”, class reported relatively high levels of HIV 
knowledge and tolerance towards HIV, but lower 
levels of self-efficacy. A second class appeared to be 
comprised of more “Rural, Traditional” women. 
They showed the lowest levels of HIV knowledge, 
least tolerant views towards HIV, and lowest levels 
of self-efficacy and risk perception.  Two other 
classes consisted of younger, more educated, urban 
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women. Women in an “Urban, Traditional” group 
(class 3) were more likely to be married than 
women in class 4, labelled “Urban, Empowered”. In 
addition, women in class 4 had fewer children, were 
more likely to be using contraception and to have 
used a condom at last sex, and all had requested an 
HIV test in the past.   
HIV status significantly varied across the classes 
(p<.0001). The “Typical” class had the highest HIV 
prevalence rate at 8%. In contrast, less than 1% of 
members associated with classes 3 and 4 were 
infected with HIV. Our initial model verifications, 
using male data from the 2003-04 Tanzania AIS and 
the female data from 2005 Côte d’Ivoire AIS, found 
similar patterns, in which a more urban, empowered 
group had significantly lower HIV status than the 
typical/referent group or a more traditional rural 
group (data not shown).
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Table 1: Model Variables  
 DHS 2003 DHS 2012 
HIV Knowledge:  1 composite variable 
Summary score for questions assessing knowledge about potential modes of HIV transmission. Correct responses 
received 1 point; incorrect responses received 0 points; a response of “don’t know” was scored as an incorrect 
response.  Examples of questions: 
Can people get the AIDS virus from mosquito bites?  
Can people reduce their chances of getting the AIDS virus by using a condom every time they have sex? 
1 variable based on 
15 items; response 
range 0-15  
1 variable based on 
10 items; response 
range 0-10 
HIV Norms:  1 composite variable 
Multi-item scale produced through exploratory factor analysis of questions assessing attitudes towards people living 
with HIV/AIDS. Examples of questions: 
Would you shake hands with someone who is infected with the virus that causes AIDS?  
If a male teacher has the AIDS virus but is not sick, shoe he be allowed to continue teaching in the school? 
1 variable based on 
factor analysis of 9 
items; 5 items 
retained; α=.64 
1 variable based on 
factor analysis of 6 
items; 5 items 
retained; α=.49 
Perceived Efficacy: 2-3 variables 
You know a place to get an AIDS test. 
You can say NO if you don’t want to have sex. 
You can ask your partner to use a condom. 
2 variables 3 variables 
HIV Testing Efficacy: 
Ordinal variable created from several questions. For DHS 2003-04, respondents received 0 if they had never 
tested before survey participation; 1 if testing was required, 2 if testing offered and they accepted; 3 if they 
requested a test on their own. For DHS 2011-12, respondents received 0 if they had never tested, 1 if tested but 
hadn’t received results, and 2 if tested and received results. 
Variable scored 0-3 Variable scored 0-2 
HIV Risk Perception: Single item 
Do you think your chances of getting AIDS are small, moderate, great or no risk at all? 
1 variable Question not asked 
Socio-demographic variables: 
Age; education; religion; marital status; total children ever born; use of effective contraception; current pregnancy 
status  
6 variables Religion, contra-
ception missing 
Household variables: 
Wealth index; female-headed household; head of household age; number household members 
2 variables 4 variables 
Geographic variables: 
Urban/rural 
1 variable 1 variable 
HIV risk indicators: 
Age at 1st sex; total lifetime sexual partners; sexual partners last 12 months; received any injections last 12 months; 
condom use last sex 
5 variables 5 variables 
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Table 2: Latent Class Models for Tanzania AIS 2003-04 and 2011-12 Female Respondents  (* Between-class 
comparison (but within each DHS, separately) significant with p<0.001.) 
 AIS 2003-04 AIS 2011-12 


































12.2 *   7.8 12.1 12.5   8.5 *    4.0   6.9 
HIV Norms, mean 0.8 *   0.4  0.7   0.8   0.9 *   0.8   0.4 
Know a place to get 
AIDS test, % 
69.4 * 20.1 100 100 98.7 *  69.4  88.4 
You can say NO to 
sex , % 
77.4 * 58.2 70.0 82.2  77.3 *  44.4  55.3 
Can ask a partner to 
use a condom, % 
    61.8 *  23.4  32.4 
Demonstrated 
Efficacy – HIV 
testing, mean 
0* 0 1.8 3   1.6 *    0.6    1.2 
Chances of getting 
AIDS are, mean 
1.1 * 0.8 1.0 1.0    
Predictor Variables        
Mean age 29.8 * 29.5 27.6 27.0 30.4 31.1 30.8 
Mean education 
(years) 
 5.8*   2.6   6.3   7.3     6.6 *   2.5   3.4 
Religion, %: 
  Moslem 
  Christian 
 











   
Currently married 
% 
78.8 * 85.1 78.2 66.8   80.3 * 79.4 89.1 
Use of effective 
contraception, % 
28.3 *   5.8 26.0 28.6    
Total children ever 
born, mean 
  3.4 *   4.0   3.0   2.2   3.4 *   4.2   4.4 
Age at first 
intercourse, mean 
17.0 * 16.2 17.9 17.6 17.5 * 16.7 16.9 
Total lifetime 
partners, mean 
  2.5 *   2.2   2.2   2.3   2.2 *   1.8   2.1 
Used condom last 
sex, % 
10.6 *   4.3 12.7 25.9 14.8 *   5.6   7.0 
Female headed 
household, % 
19.7 * 14.3 20.5 23.6 20.2 * 16.2 12.3 
Wealth index, %: *    *   
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  Poorest 
  Middle (3 
categories) 


















  2.8 
30.3 
66.8 
  2.9 
Urban, % 26.7 *   3.9 45.0 54.0  27.1   4.6   4.5 
Distal Outcome        
HIV positive, %   7.9 *   3.5  0.8   0.9      1.5 *   4.6   1.3 
 
Tanzania 2011-12 AIS Replication 
Similar to our 2003-04 analysis, the LCA identified 
subsets of women who differed significantly 
(p<0.001) by responses to all psychosocial variables. 
Unlike 2003-04, however, a three-class, rather than 
four-class, solution seemed to fit the data best. In 
addition, unlike 2003-04, the typical/referent class 
was significantly less likely to be HIV-positive 
compared to one predominantly rural class in which 
almost 5% of members were HIV- infected. The 
third class, which was also predominantly rural, was 
also lower risk, with about 1% infected.  
Geographic Variation in Class and HIV Status 
Table 3 compares the HIV prevalence and class 
affiliation of survey respondents in a subset of 
regions in Tanzania for the 2003-04 and 2011-2012 
analyses. In 2003-04, three regions had HIV 
prevalence rates of 10% or higher. However, survey 
respondents’ class affiliation varied considerably. In 
particular, almost 40% of respondents in the Dar es 
Salaam sample were affiliated with a low risk class 
(the Urban Traditional or Urban Empowered 
groups), compared to just 9% in Iringa and 13% in 
Mbeya. Drawing on HIV prevalence, class and 
regional data would suggest that Iringa and Mbeya 
might be better options as HIV prevention clinical 
trial sites than Dar es Salaam. 
In the 2011-2012 analysis, Iringa and Mbeya 
remain two of the regions with the highest HIV 
prevalence rates, but Mbeya has a higher proportion 
of respondents affiliated with the “Rural High Risk” 
group than Iringa (12% versus 1%). Several other 
regions with relatively higher HIV prevalence rates 
and high risk class composition include Rukwa, 
Myanza, Morogoro and Njombe (locations bolded in 
Table 3). 
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Table 3: Comparisons of HIV Prevalence and Class Affiliation of Survey Respondents for Selected Tanzania Regions, for AIS 2003-04 and 2011-12 Analyses 
























Low Risk  
N=1096 
 Iringa 153 12.4 70% 21% 4% 5% 
 
163 3.7 94% 1% 5% 
Mbeya 216 12.0 63% 24% 8% 5% 
 
221 4.1 72% 12% 15% 
Dar Es Salaam 314 10.2 61% 2% 25% 12% 
 
407 1.5 98% 1% 1% 
Pwani 197 7.6 73% 12% 11% 4% 
 
171 2.3 92% 4% 4% 
Kilimanjaro 160 7.5 69% 12% 15% 4% 
 
174 1.7 94% 3% 3% 
Tabora 266 6.4 44% 47% 6% 3% 
 
343 0.6 75% 7% 18% 
Shinyanga 204 6.4 19% 73% 6% 2% 
 
239 2.9 64% 12% 24% 
Lindi 205 6.3 77% 13% 6% 3% 
 
236 0.9 89% 5% 6% 
Mtwara 199 6.0 88% 8% 2% 2% 
 
216 1.4 90% 5% 5% 
Rukwa 237 5.9 52% 43% 2% 3% 
 
237 3.4 66% 15% 19% 
Mwanza 261 5.8 58% 30% 7% 5% 
 
308 2.6 72% 13% 15% 
Tanga 204 5.4 61% 26% 8% 5% 
 
225 0.9 72% 14% 14% 
Arusha 193 5.2 58% 20% 13% 8% 
 
223 2.2 70% 12% 18% 
Morogoro 191 4.7 72% 12% 12% 4% 
 
253 2.4 83% 11% 6% 
Njombe n/a n/a n/a n/a n/a n/a 
 
181 3.9 90% 6% 4% 
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Discussion 
An important challenge in recruitment for clinical 
trials of new HIV prevention technologies is the 
need to identify populations who are at high risk of 
HIV – that is, likely to be exposed at some point 
during trial participation, but who are HIV negative. 
In some South African sites involved in recent 
microbicide trials, as many as two-fifths of 
prospective trial participants were not eligible 
because they were determined to be HIV-infected 
at screening (Parikh, Kiepiela et al. 2013). 
Consequently, the challenge is to develop 
recruitment mechanisms that identify high incidence 
but avoid high prevalence. By removing AIS 
respondents who had been previously diagnosed 
with HIV and knew their status, we believe our 
approach to sample selection approximates HIV 
incidence, thereby refining our ability to characterize 
population groups who are either most or least at 
risk due to more recent trends. 
Our use of LCA for population segmentation is a 
highly exploratory approach. Nevertheless, our 
analyses were able to identify and characterize 
subpopulations either at lower HIV risk than the 
norm in 2003-04, or at higher risk in 2011-12. 
Despite seeming differences in the 2003-04 and 
2011-12 models, there are some interesting 
similarities in findings. For example, lower risk 
classes (classes 3 and 4 in 2003-04 and class 1 in 
2011-12) had high HIV knowledge and HIV norms 
scores; despite changes in how the testing efficacy 
variable was measured, lower risk groups were 
much more likely to know a place where one could 
get tested and to have gotten tested, than higher 
risk groups. Indeed, in the 2003-04 women’s and 
men’s samples, having requested a test oneself, 
rather than having just accepted a test that was 
offered as part of a healthcare visit, differentiated 
the “Urban Empowered” class from other classes. In 
contrast, women in classes with a higher proportion 
of HIV-positive members tended to be older, 
poorer, less educated, and more likely to reside in 
rural areas.  
Theoretically, minimizing recruitment of 
individuals who fit a lower risk profile or increasing 
recruitment of those with higher risk profiles would 
improve the ability of HIV prevention trials to 
determine effectiveness of new products. This could 
potentially be accomplished by refining trial eligibility 
criteria to include psychosocial indicators (HIV 
knowledge, norms, risk perception and/or self-
efficacy), in addition to the socio-demographic and 
risk indicators typically included on screening forms. 
However, political sensitivities would also need to 
be considered. A more politic approach would be to 
identify regions with high proportions of individuals 
in classes associated with higher prevalence.  Our 
LCA analysis of DHS/AIS data provides a relatively 
low-cost, rapid approach to augment the site 
selection process.   
Differences between 2003-04 and 2011-12 Models 
The differences in our 2003-04 and 2011-12 models 
may be a result both of changes in the HIV epidemic 
itself, as well as changes in some of the key 
measured variables on which the models are based. 
(Indeed, changes in the DHS/AIS surveys between 
these two periods may also be a reflection of 
changes in the epidemic.)   Between 2002 and 2012, 
the number of HIV-infected persons living in Africa 
who were receiving antiretroviral therapy increased 
150-fold. Women – particularly adult women of 
reproductive age were most likely to have benefited 
from expanded access to HIV treatment and care, 
given efforts to scale up prevention of mother-to-
child treatment services. In Tanzania, an estimated 
68% of pregnant women were tested for HIV in 
2012 (World Health Organization 2013). HIV testing 
questions within the AIS 2011-12 women’s survey 
were primarily anchored to testing within the 
context of antenatal care, likely reflecting structural 
changes in how HIV testing is currently implemented 
in Tanzania.   
Despite unprecedented expansion in HIV testing 
and treatment access, the majority of HIV-infected 
individuals have never been diagnosed. Structural 
factors, logistical and operational issues and social 
factors, including stigma, continue to act as barriers 
to HIV-related services (World Health Organization 
2013). The NIH has called for innovative strategies 
to identify persons unaware of their HIV infection in 
specific high-risk populations and settings on an on-
going basis. Our 2011-12 analysis found that women 
with a higher risk for HIV continued to have lower 
HIV testing knowledge and efficacy, suggesting that 
some continue to be missed by provider-initiated 
testing and remain at risk.  Finally, the most recent 
AIS did not include a question on HIV risk 
perception. Yet, individual perception of risk plays 
an important (albeit complicated) role in 
determining initiation and maintenance of 
prevention behaviours (de Zoysa, Sweat et al. 1996, 
Misovich, Fisher et al. 1997, Khawcharoenporn, 
Kendrick et al. 2012, Van Damme, Corneli et al. 
2012, Van Damme and Corneli 2013, Corneli, Wong 
et al. 2013), and may also affect retention and 
adherence within HIV prevention clinical trials. 
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Unfortunately, because of these differences in 
the measurement of some key variables, we cannot 
easily explore time effects across the models. 
Nevertheless, there are some remarkable 
similarities between the results of the two models.  
Notably, despite changes in the epidemic, less 
knowledge of where to get an HIV test, lower HIV 
testing efficacy, and HIV knowledge in general seem 
to identify a rural sub-population that may be at 
increased risk of HIV. These lower scores on HIV 
knowledge and efficacy measures may reflect 
pervasive social and structural factors that continue 
to undermine HIV prevention behaviours and 
perpetuate risk among some populations.   
Limitations 
This analysis has several limitations. As we 
pointed out, the use of LCA for population 
segmentation is a very exploratory process involving 
relatively subjective decisions about which indicators 
to include, how many classes to retain and how each 
class should be labelled. Therefore, our analysis of 
HIV prevalence, class affiliation and region provides 
some useful information to consider when 
identifying potential trial sites, but should not be 
considered conclusive. For example, clinical trial site 
selection must also consider the existence and 
quality of physical and human resources needed to 
implement trials. In addition, our use of a modified 
HIV prevalence indicator, by removing individuals 
from our analysis who knew of their HIV positive 
status prior to DHS interview, may not be the best 
indicator of incidence. However, the modification 
does increase the likelihood that the latent classes 
we identified reflect the psychosocial characteristics 
of those who may be “at-risk” but not currently 
living with HIV. Finally, the analysis also has several 
strengths; it makes low cost use of existing data and 
is relatively straight-forward and easily replicated for 
other countries, as and when country-level 
biomarker data become available. 
Conclusions 
Given that most site identification activities currently 
rely on personal networks and/or intensive – but 
limited -- primary data collection efforts, this analysis 
has the potential of providing a more systematic, 
inexpensive, and relatively rapid approach to 
identifying countries, regions and sub-districts for 
HIV prevention trials. By comparing the models 
developed from different country or regional-level 
DHS data, it may also provide some new insights 
into the role that culture plays in shaping HIV risk –
leading to better tailoring of recruitment strategies 
to the local contexts in which a trial is situated. 
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